Visudyne: Clinical Trials

5 trials of Visudyne, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 withdrawn. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 4, Withdrawn 1

Follow Visudyne: new trials by email Literature Review of Visudyne trials Research Report on Visudyne

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy
Ranibizumab, Photodynamic laser treatment (PDT), Triamcinolone Acetonide - Exudative Age Related Macular Degeneration
Phase 4WithdrawnWake Forest University Health Sciences2023-03-302024-03-22
Aflibercept in Polypoidal Choroidal Vasculopathy
Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321), Visudyne - Neovascular Macular Degeneration
Phase 4CompletedBayer3332014-05-292020-12-02
Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy
Verteporfin Photodynamic Therapy, Ranibizumab - Polypoidal Choroidal Vasculopathy
Phase 4CompletedNovartis612008-04-012011-04-19
Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration
Ranibizumab, Verteporfin - Age-Related Maculopathy, Choroidal Neovascularization
Phase 4CompletedOklahoma State University Center for Health Sciences312007-05-012020-11-06
Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment
Ranibizumab, Ranibizumab plus Photodynamic therapy - Age-Related Macular Degeneration
Phase 4CompletedIllinois Retina Associates102007-02-012012-03-28

Conditions studied

Macular Degeneration (4)  ·  Choroidal Neovascularization (1)  ·  Polypoidal Choroidal Vasculopathy (1)  ·  Polyps (1)

Sponsors

Bayer (1)  ·  Illinois Retina Associates (1)  ·  Novartis (1)  ·  Oklahoma State University Center for Health Sciences (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (3)  ·  Hong Kong (2)  ·  Singapore (2)  ·  South Korea (2)  ·  Taiwan (2)  ·  Australia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Japan (1)  ·  Thailand (1)

Top investigators

John Saurino, DO (1)  ·  Mark Nelson, MD (1)  ·  Pauline T Merrill, MD (1)  ·  Raymond Townsend, MD (1)  ·  Scott J Westhouse, DO (1)

Results publications

PMID 22426346, PMID 25758601, PMID 29801063, PMID 41903075